Lise Barnéoud is a French freelance science journalist, trained in biology. Her work has appeared in Le Monde, Mediapart and The New Scientist. She is the author of TV documentaries and books (last one on vaccination). She received several awards (Prix Varenne, French science journalist award, among others).
 

Basic information

Name
Lise Barneoud
Expertise
Science journalism
Country
France

Supported projects

Behind The Pledge - How EU money is spent for Covid19 drugs

  • Healthcare
  • Industry

BRUSSELS - How did we come to pay gold for a drug whose effectiveness has not been proven? This is the story of Remdesivir, a drug developed by the American company Gilead Sciences with large public funds to combat Ebola, and in July approved by the European Medicines Agency with "conditional authorisation" as the first antiviral against Covid 19.